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Countywide antibiotic resistance patterns may provide additional information from that obtained from
national sampling or individual hospitals. We reviewed susceptibility patterns of selected bacterial strains
isolated from blood in San Francisco County from January 1996 to March 1999. We found substantial hos-
pital-to-hospital variability in proportional resistance to antibiotics in multiple organisms. This variability
was not correlated with hospital indices such as number of intensive care unit or total beds, annual admis-
sions, or average length of stay. We also found a significant increase in methicillin-resistant Staphylococ-
cus aureus, vancomycin-resistant Enterococcus, and proportional resistance to multiple antipseudomonal
antibiotics. We describe the utility, difficulties, and limitations of countywide surveillance. 
any national sampling and hospital surveillance systems
exist to monitor antimicrobial resistance patterns in bac-
teria (1-4). Previously, organisms resistant to multiple antibiot-
ics were largely confined to hospital settings and were
typically described through studies involving single hospitals
or intensive care units (ICUs). These single-hospital studies
often reported substantially different resistance patterns from
one another (5-7). National surveillance systems provided key
data on large-scale resistance trends, but, similarly, continued
to show marked variability in proportional resistance among
participating hospitals (1-3,8,9). 
We hypothesized that countywide surveillance data would
not only provide information on changes in bacterial antimi-
crobial resistance but also potentially identify hospital demo-
graphic data to account for interhospital variability in
resistance patterns. Additionally, countywide surveillance
should provide greater insight into the relationship between
single hospitals and their neighboring communities as data
accumulate to support the spread of resistant organisms from
the hospital into the community and vice versa. Morgan et al.
(8) reported data from Wales that 66% of patients colonized or
infected with methicillin-resistant Staphylococcus aureus
(MRSA) are being discharged to their homes, leading to risks
of intrafamilial transmission (10-12). Goetz et al. (6) showed
that health-care workers similarly bring resistant organisms
home. Additionally, outpatient dialysis units, rehabilitation
centers, and outpatient intravascular devices have been shown
to be reservoirs of colonization with MRSA and vancomycin-
resistant Enterococcus (VRE) in many patients in the commu-
nity (13-16). 
MRSA and VRE colonization and infection in the absence
of hospital risk factors are also being increasingly recognized
in the community (17-22). Day-care centers and isolated com-
munities may play a notable role (20,23). Patients colonized
from these community reservoirs can subsequently cause hos-
pital outbreaks after admission (24). 
As hospital and community colonization and infection
begin to exert pressure on one another, single-hospital surveil-
lance data may become less useful in isolation. Countywide
surveillance may provide more insight into the sources and
extent of outbreaks and prompt focused investigations into the
spread and containment of resistant organisms. 
We conducted an observational study to evaluate the
changes in antibiotic resistance in selected bacteria isolated
from blood in San Francisco County, California, to determine
if these changes were associated with specific hospital demo-
graphics and to define the utility, limitations, and potential
areas of improvement in a county-based surveillance system. 
Methods
All bacterial strains recovered from blood were identified
from available microbiology department records of all 13 hos-
pitals in San Francisco County from January 1, 1996, to March
31, 1999. For three hospitals (4,5,9), data from 1996 had been
purged and were no longer available. For each isolate, data
were collected on organism type and susceptibility pattern.
Information was also obtained on the ward, age, and gender of
the patient. Only the first positive blood culture of a given spe-
cies was included for a single patient throughout the study
period, regardless of susceptibility pattern. Cultures positive
for S. epidermidis were considered representative of clinical
bacteremia if at least two isolates with identical susceptibility
patterns were obtained from a minimum of two separate sets of
blood cultures. Each such set was considered a single bactere-
mic event. All other cultures positive for S. epidermidis were
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excluded, as were other common skin contaminants (e.g., Pro-
pionibacterium acnes, Peptostreptococcus, Corynebacterium). 
All but one hospital used automated systems (VITEK
[bioMerieux Vitek, Hazelwood, MO] or Microscan [Baxter
Laboratories, West Sacramento, CA]) for the susceptibility
testing of gram-negative bacteria. All hospitals used Kirby-
Bauer disk-diffusion techniques for the evaluation of suscepti-
bility profiles for Streptococcus pneumoniae and other strepto-
coccal species according to National Committee for Clinical
Laboratory Standards (NCCLS) guidelines. Kirby-Bauer
results were supplemented by E-testing. One hospital (12) per-
formed all susceptibility testing using Kirby-Bauer disk-diffu-
sion techniques.  All microbiology laboratories used MIC
breakpoints established by the NCCLS. The annual number of
blood culture sets processed by each microbiology laboratory
was also obtained. 
Data from five hospitals were obtained as text files or
Microsoft Excel (Redmond, WA) files and subsequently
imported into a Microsoft Access (Redmond, WA) database.
Data from four hospitals were obtained in printed form,
scanned as image files, converted into text files using Text-
Bridge Pro 98 (ScanSoft Inc., Peabody, MA), and imported
into the database. All scanned entries were verified for accu-
racy. Data from the remaining four hospitals were obtained
from stored index cards, entered manually into the database,
and verified for accurate entry. 
We also obtained bed size and census data for all 13 hospi-
tals in San Francisco County. Total hospital admissions were
tabulated from quarterly administrative records from 1996
through 1998. For each hospital, average length of hospital
stay was obtained from publicly available resources (25). 
Data Analyses
The number of isolates for each species was tabulated for
each year and for the entire study period. Only species for
which the total number of countywide isolates exceeded 100
during the study period were further evaluated. For each
organism, proportional annual resistance to an antibiotic was
calculated as the yearly number of organisms with intermedi-
ate or full resistance divided by the total number of organisms
isolated in San Francisco County that year. Because of labora-
tory variability in susceptibility testing, not all isolates are
included in descriptions of proportional resistance. 
Means were calculated from the annual countywide per-
centages in each of the 4 years studied. Percent annual resis-
tance was determined for any antibiotic tested in >50 isolates
and analyzed for increasing or decreasing annual trend from
1996 through 1999. Data for 1999 were based on the first
quarter culture results. Strains with full or intermediate resis-
tance to an antibiotic were counted as resistant in all statistical
analyses. 
Organisms demonstrating increasing or decreasing annual
resistance to a given antibiotic (p<0.05) were further described
by calculating mean proportional resistance over the study
period according to categories of hospital, ward, patient age
(in 10-year intervals), and patient gender. Spearman rank tests
were used to determine any correlation between hospital indi-
ces (beds, annual admissions, average length of stay) and pro-
portional antibiotic resistance. P values were not adjusted for
the effect of multiple comparisons. P values remained
unchanged with respect to alpha level (0.05) after removal of
the three hospitals missing data from 1996.
Results
A total of 11,573 bacterial strains were recovered from
blood cultures by the 13 hospitals. After excluding duplicate
cultures, we had 8,072 remaining clinical isolates. 
Information on hospital size, census, and blood culture
volume is provided in Table 1. Despite being distinct and non-
adjoining, hospitals 4 and 5 are reported together because of
unified microbiology and administrative centers. Hospital 13
is a skilled nursing facility. On average, 74,600 sets of blood
cultures were processed each year in San Francisco County;
9.9% of these were positive for bacterial species. 
Of the 8,072 isolates, Staphylococcus aureus (1,858),
Escherichia coli (1,634), and S. pneumoniae (725) were the
most common organisms. The numbers of S. aureus, Entero-
coccus faecalis, Bacteroides fragilis, E. coli, and Serratia
marcescens increased annually during the 4-year period. Four-
teen species had >100 isolates and were considered for further
analysis (Figure 1). These 14 organisms accounted for 85% to
86% of all yearly totals. 
Gram-Positive Organisms
The proportion of MRSA and E. faecium resistant to van-
comycin (VRE faecium) increased annually (Figure 2). Coun-




















1 482 47 20,340 6.6 16,325 11
2 371 32 14,305 3.8 9,108 9
3 304 30 18,843 7.5 12,929 13
4,5b 302 31 10,893 5.8 10,800 6
6 284 12 5,939 8.3 3,580 12
7 253 15 7,982 7.3 4,865 9
8 240 15 9,887 7.6 5,475 6
9 221 18 6,139 6.6 2,582 11
10 209 19 6,655 6.7 4,974 14
11 209 8 3,293 9.3 2,515 10
12 59 7 2,260 5.4 1,464 13
13c 1,280 0 1,211 351.2 N/A —
aICU beds includes medical, surgical, cardiac, and neurologic adult critical care.
bAdministration, microbiology laboratories merged. Average number per hospital 
given.
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tywide, the proportion of MRSA isolates rose from 18.1%
(1996) to 26.1% (1999) (p<0.001). In total, MRSA constituted
22.4% of all S. aureus isolates, including 19.6% of emergency
department isolates and 15.9% of isolates in the outpatient set-
ting (Table 2). Methicillin resistance in S. aureus isolates was
<15% in patients <20 years of age and >20% in all other age
groups, with the exception of 30- to 39-year-olds (17.6%)
(Table 3). Proportional resistance did not vary by patient gen-
der.
During the study period, 124 VRE isolates and 157 vanco-
mycin-sensitive  Enterococcus isolates were unspeciated.
Among the speciated E. faecium isolates, the percentage resis-
tant to vancomycin rose from 0% to 66.7% in the 4-year
period (p<0.001). VRE faecium was most frequently isolated
from inpatient adult wards, but six isolates were cultured from
emergency department and outpatient settings. Over 66% of E.
faecium isolates from skilled nursing facilities were resistant
to vancomycin (Table 2). VRE isolates exceeded 40% in all
age groups with the exception of <10-year-olds (22.2%) (Table
3). Of note, VRE faecium isolates showed increasing annual
resistance to doxycycline (from 30% to 68%; p = 0.02).
Even after the skilled nursing facility (hospital 13) was
excluded, the percentage of MRSA and VRE faecium isolates
varied substantially among individual hospitals (MRSA 12.5%
to 37.5%, VRE faecium 12.5% to 80.0%). There was no corre-
lation between proportional resistance and number of ICU or
total hospital beds, number of annual admissions, or average
length of ICU or total hospital stay. However, for both organ-
isms, there was increasing proportional resistance among adult
wards in the following order: outpatient wards, emergency
department, medical and surgical floors, medical and surgical
ICUs, and skilled nursing facility wards. Notably, a substantial
number of VRE and MRSA isolates were cultured within the
first 24 to 48 hours of hospital admission (Figure 3). 
Of the 678 isolates of S. pneumoniae, 13.6% were resistant
to penicillin. Proportional resistance increased from 10.8% (21
isolates) in 1996 to 14.6% (27 isolates) in 1998, but this
increase was not statistically significant. Proportional resis-
tance was highest at the extremes of age (16.4% in patients
>70 years of age and 19.3% in patients <10 years of age (Table 3). 
Gram-Negative Organisms
Countywide, E. coli (1,634 isolates), Klebsiella pneumo-
niae (428 isolates), and Pseudomonas aeruginosa (260 iso-
lates) were the most frequently isolated gram-negative bacilli.
This was true in all inpatient and outpatient wards with the
Figure 1. All bacterial species that were isolated from blood in >100
persons, January 1996 through March 1999, all hospitals in San Fran-
cisco County, California. Each bar is divided by yearly totals. Total num-
ber of isolates obtained during the study period is given above each
bar. MRSA = methicillin-resistant Staphylococcus aureus; VRE = van-
comycin-resistant Enterococcus.
Figure 2. Increase in percentage of Staphylococcus aureus isolates
resistant to methicillin and increase in percent of Enterococcus faecium
resistant to vancomycin on a yearly basis from 1996 through the first
quarter of 1999. Number of isolates per year, regardless of susceptibil-
ity, appears above each bar. Tests of trend showed significant
increases in percent resistance for both organisms.
Table 2. Proportionala resistance of highly resistant organisms by 














Skilled nursing facility 38.0% (100) 66.7% (6) 8.3% (12)  
Med/surg ICU  27.2% (298)  50.0% (58)  13.3% (75)  
Pediatric ICU  30.3% (33)  25.0% (4)  0% (2)  
Med/surg floors  21.8% (709)  47.8% (92)  12.0% (166)  
Pediatric floors  9.1% (33)  60.0% (5)  40.0% (10)  
Emergency department  19.6% (424)  22.7% (22)  9.5% (305)  
Outpatient  15.9% (171)  12.5% (8)  23.6% (72)  
Other/unknown  28.6% (7)  100% (1)  32.4% (34)
Total 22.4% (1,782) 44.9% (196) 13.6 (678)
aProportional resistance refers to the proportion of isolates of that species that is resistant 
to the indicated antibiotic.
bTotal number of species isolates given in parentheses.  Percentages for small numbers of 
total isolates should be cautiously interpreted.
ICU = intensive care unit.RESEARCH
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exception of skilled nursing facilities, where Proteus mirabilis
was the most common gram-negative isolate after E. coli. Pro-
portional resistance by ward for selective gram-negative
organisms is shown in Table 4.
Among  E. coli isolates, resistance to trimethoprim-sul-
famethoxazole averaged 28% and resistance to ciprofloxacin
averaged 3%. There was no resistance to fluoroquinolones
among E. coli isolates from pediatric wards. Increasing annual
resistance to ticarcillin-clavulanate was seen in both E. coli
(6% to 16%, p=0.03) and K. pneumoniae (0% to 18%, p=
0.007) isolates. 
P. aeruginosa isolates showed increasing annual county-
wide resistance to ciprofloxacin (7% to 21%, p=0.005),
ceftazidime (6% to 16%, p=0.02), and imipenem (2% to 18%,
p=0.004) (Figure 4). Resistance to each of these three antibiot-
ics exceeded 10% in adult ICU and adult medical and surgical
wards. In fact, in these settings, ciprofloxacin resistance
approached 20% countywide. No isolates resistant to ciprof-
loxacin were cultured from pediatric wards (Table 4). Resis-
tance to gentamicin (15%) and piperacillin-tazobactam (12%)
also increased but was not statistically significant. 
There were 182 E. cloacae and 116 S. marcescens isolates
from January 1996 through March 1999. Ciprofloxacin resis-
tance averaged 4% among E. cloacae isolates and 6% among
S. marcescens isolates. S. marcescens isolates also showed
increasing annual proportional resistance to gentamicin (0% to
14%, p=0.02) and piperacillin (4% to 29%, p=0.01).
Resistance to ceftazidime, which can be predictive of
inducible and extended-spectrum-beta-lactamases, was found
in the following overall mean proportions in the study period:
E. coli (1%), P. mirabilis (1%), K. pneumoniae (1%), S.
marcescens (8%), P. aeruginosa (13%), and E. cloacae (39%).
Only P. aeruginosa isolates demonstrated an increasing linear
annual trend (p = 0.02). 
 Discussion
San Francisco County has a population of approximately
735,000 and covers 46.7 square miles (26). It comprises multi-
ple racial and ethnic groups (black 10.9%, Hispanic 13.9%,
Asian 29.1%, and Native American 0.5%) and is served by 13
hospitals. We have shown that county surveillance of bacterial
resistance is a useful addition to local hospital surveillance,
particularly as antibiotic-resistant bacteria increasingly spread
from hospital to hospital and into the community at large.
Across the county, annual proportions of MRSA and VRE
isolates significantly increased over the 4-year period.
Pseudomonal strains resistant to fluoroquinolones, ceftazi-
dime, or imipenem also increased annually. These data allow
us to distinguish countywide outbreaks and trends from single-
hospital changes in resistance patterns, and enable infection
control efforts to expand or narrow to the appropriate scale.
With awareness programs, county surveillance can broaden
physicians’ knowledge of their hospital’s effects on the com-
munity, as well as the effects of neighboring hospitals on resis-
tance patterns in their particular hospital. 
Additionally, county surveillance that includes subcatego-
rization of isolates by ward is invaluable in identifying patients
at high risk and locations for transmission of resistant bacteria.
Not surprisingly, we report our highest proportion of MRSA
and VRE isolates from ICU and nursing home units. Neverthe-
less, ward variability across hospitals was substantial. Large
interhospital differences can lead to further study of ward
practices that foster or abate transmission. Awareness can
prompt hospital infection control personnel to ensure well-
described preventive measures such as swabbing and isolation
precautions for VRE and MRSA in ICU settings (27-30) and
nasopharyngeal swabbing and eradication of MRSA in hemo-
dialysis wards (1,31). We also identify several MRSA and
VRE isolates from outpatient and emergency department
Table 3. Proportionala resistance of highly resistant organisms by 















<10 14.3 (98) 22.2 (9) 19.3 (83)
10-19 8.1 (37) 50.0 (4) 20.0 (5)
20-29 21.7 (83) 50.0 (8) 0 (26)
30-39 17.6 (250) 42.1 (19) 13.4 (142)
40-49 21.8 (353) 41.4 (29) 8.7 (138)
50-59 24.8 (234) 43.8 (32) 11.5 (78)
60-69 29.1 (227) 45.5 (44) 10.2 (49)
70-79 24.8 (258) 55.9 (34) 15.6 (64)
>80  22.8 (237) 41.2 (17) 17.2 (64)
aProportional resistance refers to the proportion of isolates of that species that is 
resistant to the indicated antibiotic.
bTotal number of species isolates given in parentheses. Percentages for small num-
bers of total isolates should be cautiously interpreted.
Figure 3. Plot of the number of methicillin-resistant Staphylococcus
aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) iso-
lates by hospital day of admission. An early peak is noted, correspond-
ing to patients entering the hospital with MRSA or VRE bacteremia.
Subsequent cases likely represent nosocomial acquisition.Emerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 199
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settings. Whether or not these represent true community-
acquired strains or strains from patients recently released from
hospital settings, they suggest that highly resistant bacterial
outpatient infections and infectivity are increasing, a result
consistent with recent studies (19,21,22).
We also evaluated whether the wide variability in the pro-
portions of resistant bacteria among San Francisco hospitals
was linked to hospital indices. In contrast to previous nation-
wide sampling studies, none of this variability was correlated
with the number of hospital ICU beds (3), total beds (1,2,31),
annual admissions (32), or annual mean length of stay. This
may be due to our small number of hospitals, leading to lim-
ited power to detect such correlations. Alternatively, local
community and hospital factors (e.g., increasing care of mod-
erately ill patients at home [8], increasing home intravenous
antibiotics [15], active transfer of patients between hospitals
[33,34], and community-acquired resistant organisms) may
now be diminishing the effect of hospital size, census and
length of stay on proportional resistance.
There are many additional advantages to a countywide sur-
veillance system for antimicrobial resistance. First, it can help
reassess therapy. The 28% trimethoprim-sulfamethoxazole
resistance in E. coli raises questions about the optimal empiric
treatment of urinary tract infections in patients at high risk for
bacteremia or urosepsis. Likewise, distinguishing resistance in
the outpatient versus inpatient setting can guide empiric ther-
apy in the appropriate setting. 
Second, in studying a larger populace, we can obtain suffi-
cient numbers to study uncommon organisms. Similarly, coun-
tywide surveillance provides a means to identify and confirm
novel resistant pathogens. In our study, one MRSA isolate
with intermediate resistance to vancomycin and three vanco-
mycin-resistant S. epidermidis isolates were noted in microbi-
ology laboratory reports. As with the organisms recently
reported in the United States (35-37), these were reported from
nontertiary hospitals. Nevertheless, our reports are uncon-
firmed and likely represent laboratory error. However, if sur-
veillance could be expedited to real-time use, such reports
could be investigated and confirmed rather than dismissed. At
its worst, this suggests that highly resistant organisms may be
escaping deserved attention and reaction.
Third, countywide surveillance engenders further hypothe-
ses and research regarding interhospital and community trans-
mission of resistant organisms. For example, our finding that
20% of emergency department S. aureus isolates are methicil-
lin-resistant provides a flag to further study which county
areas have the highest percentages of resistant S. aureus and
which risk factors are involved (e.g., recent hospital admission
[21,22], associated hemodialysis centers [8,38] or nursing
homes [21,22], or intravenous drug use [39]). The finding that
P. mirabilis bacteremia is more common in nursing home
wards raises questions about preventing urinary tract infec-
tions in that setting. The relative lack of fluoroquinolone resis-
tance in pediatric gram-negative isolates is likely due to the
avoidance of fluoroquinolones in children because of potential





















9.1% (88) 2.2% (92) 50% (6) 8.3% (12) 25% (12) 20.0% (10) 40.0% (5)
Med/surg ICU 8.4% (166) 1.9% (160) 53.4% (43) 21.5% (65) 15.9% (63) 11.9% (59) 12.1 (33)
Pediatric ICU 18.5% (27) 0% (28) 18.2% (11) 0% (13) 7.7% (13) 9.1% (11) 0% (11)
Med/surg floors 8.4% (586) 4.3% (564) 47.2% (53) 19.1% (89) 12.5% (88) 12.2% (74) 9.5% (21)
Pediatric floors 25.0% (16) 0% (16) 27.3% (11) 0% (10) 0% (10) 0% (8) 0% (6)
Emergency 
department
8.4% (536) 2.6% (549) 32.3% (31) 23.5% (34) 5.9% (34) 6.7% (30) 0% (17)
Outpatient 8.6% (117) 1.6% (123) 4.8% (21) 4% (25) 4.0% (25) 0% (22) 0% (15)
Other/unknown 11.1% (18) 0% (18) 0% (0) 0% (1) 0% (1) 0% (1) 0% (0)
Total 8.8% (1,554) 2.9% (1,550) 38.1% (176) 16.5% (249) 11.4% (246) 9.8% (215) 7.3% (109)
aTotal number of species isolates given in parentheses. Percentages for small numbers of total isolates should be cautiously.
ICU = intensive care unit.
Figure 4. Yearly percent resistance to ciprofloxacin, ceftazidime, imi-
penem, and piperacillin in Pseudomonas aeruginosa isolates from
blood. Increasing proportional resistance occurred in three of the four
antibiotics commonly used to treat this organism. Annual number of
isolates tested to each antibiotic is given at the top of each graph.RESEARCH
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detrimental cartilage effects. The study of fluoroquinolone-
resistant organisms during the transition years from pediatric
to adult medicine may provide insight into the quantity and
duration of antibiotic needed to produce selection pressure, as
well as the speed and durability of emerging resistance.
Our surveillance method had several limitations. Chart
review would have been an invaluable addition in distinguish-
ing between community-acquired and recent hospital or nurs-
ing home acquisition of resistant organisms. Second, we did
not collect or confirm isolates; thus, although our results
reflect microbiologic data actually presented to ordering phy-
sicians, they are subject to laboratory differences in speciation
and susceptibility determination. Notably, not all organisms
were fully speciated or tested against the antibiotics of interest.
Fortunately, this occurred in a small proportion of bacteria.
Third, we do not provide information on antibiotic use, which
is known to be a major determinant of bacterial antibiotic
resistance. Fourth, countywide trends can be driven by trends
seen in the largest hospitals, particularly since smaller hospi-
tals often lack sufficient numbers of isolates to make statistical
analyses meaningful. This was notable for our data on propor-
tional increases in VRE, which were largely driven by three
hospitals. On the contrary, MRSA trends were not limited to a
few hospitals, nor were they limited to the largest hospitals in
the county. No hospital showed a significant decreasing trend
in the proportion of MRSA isolates.
Areas for improvement include methods to computerize
microbiologic data storage in a universal format. This would
expedite surveillance and allow real-time collection and iden-
tification of unusually resistant organisms, as well as provide
sentinel data regarding countywide outbreaks. In addition,
linking of patient information to microbiologic data would
have expedited acquisition of sex, gender, and ward informa-
tion. Furthermore, despite NCCLS guidelines, a fair amount of
variability exists in laboratory practices and susceptibility pan-
els. Further standardization of these practices would help
ensure the reliability of merging data among hospitals. 
Without a doubt, the greatest utility of countywide surveil-
lance lies in its ability to ask screening questions that prompt a
more thorough investigation of specific hospitals, wards, or
age groups at particular risk for acquiring or transmitting
highly resistant organisms.
We have shown how several such questions were raised by
our surveillance of bacteremias in San Francisco County and
described its many advantages. We have further defined our
limitations and difficulties in performing such surveillance, in
the hope that this will be helpful to further similar surveillance
efforts.
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